[23] Before the 1993 publication of Chang's results, Gallo's lab was accused and initially found guilty of "minor misconduct" by the Office of Scientific Integrity in 1991, and then by the newly created Office of Research Integrity in 1992 for the misappropriation of a sample of HIV produced at the Pasteur Institute
Factors Driving the Cost of Semaglutide Patent Protection: Ozempic, Wegovy, and Rybelsus are currently under patent protection, which prevents other companies from producing lower-cost generic versions
Data from PIONEER 1 were not included because oral semaglutide was given as monotherapy [12], PIONEER 2 was excluded because all patients randomised to oral semaglutide or comparator were receiving background metformin (and no other background glucose-lowering medication) [13], and PIONEER 6 was excluded because it was a cardiovascular outcomes trial [14]
The combination was created to combine two independent satiety pathways in a single, weekly schedule
One study mentioned that endocrine therapies that are given as adjuvant treatments (such as aromatase inhibitors) can cause weight gain and obesity in breast cancer patients, and that GLP-1R agonists could reverse this effect